Raghav Aggarwal

Vice President



Drug Pricing, Health Care Payment Policy, Medicare Part D

Professional Experience

Centers for Medicare and Medicaid Services (CMS), U.S. Senate Committee on Finance, Executive Branch

Raghav Aggarwal is a Vice President with BGR’s Health and Life Sciences Practice. He has significant experience as a leader in the federal healthcare policy space, having held a variety of senior roles within the Executive Branch and on Capitol Hill. He possesses deep knowledge and expertise in drug pricing, health care payment policy, and the federal regulatory and legislative processes.

Before joining BGR, Raghav most recently served as Senior Advisor for the Department of Health and Human Services (HHS) Centers for Medicare and Medicaid Services (CMS) leadership and helped oversee a vast array of policy and operational work for the Agency related to a more than $400 billion per year health care portfolio, including the implementation of the drug pricing and payment reform provisions of the Inflation Reduction Act of 2022.

Raghav also served on detail as Senior Health Policy Advisor with the Majority Staff of the U.S. Senate Committee on Finance, where he managed legislation and advised the Chairman on the prescription drug pricing, Medicare Part D, and Medicare Advantage policy portfolios, among other health care issues. During his time with the Senate Finance Committee, Raghav most notably led the development of the drug pricing and payment reform policies included in the Inflation Reduction Act of 2022 and helped to successfully negotiate passage of the landmark legislation.

Raghav began his federal career during the Obama administration. Prior to and after his time with the Senate, Raghav served as a lead advisor and technical authority on the Medicare program for senior officials across the Executive Branch under three different administrations. During his time with CMS, he executed multiple initiatives including cross-cutting projects and completed special assignments for senior political and career leadership on a broad range of significant management, operational, and policy issues. He also contributed to the development of legislative, regulatory, and litigation strategies, participating in senior-level discussions and planning sessions, collaborated with policy staff to execute and brief senior leadership on complex program-related studies and data analyses to provide critical quantitative and qualitative context for policy decisions, and spearheaded the development, clearance, and implementation of policy guidance and regulations related to the Medicare Advantage and Part D programs, including the annual rate notices.

During his CMS tenure, Raghav oversaw the formulation, rollout, and implementation of significant Medicare Advantage and Medicare Part D policy changes related to the treatment of manufacturer rebates, payment for insulins, benefit design and reporting requirements, value-based insurance design, risk adjustment, applications of Medicare Advantage encounter data, end-stage renal disease enrollment and payment, Medical Loss Ratio, coverage and payment of COVID-19 vaccines and testing, plan formulary design, Parts C and D coverage and contract requirements, and Parts C and D Star Ratings.

Raghav has received numerous honors and awards for his meaningful contributions to federal health care policy, including the HHS Secretary’s Award for Excellence in Management, one of the highest honors granted by the Department and conferred by the Secretary.

He previously interned for the late U.S. Senator Dianne Feinstein (D-CA) and served as a Fellow in the Office of the former Secretary of the Interior, Ken Salazar.

Raghav has a Master of Public Administration and Bachelors of Sciences in Economics, Mathematics, and Public Policy from the University of Southern California.